Physician profile
Tarick Doleh
NPI 1477725448
$2,213.89
in general payments reported to CMS, 2019-2025
20 companies · $519 in 2025
The $519 reported for 2025 was more than what 90% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $134 · 2021: $265 · 2022: $147 · 2023: $293 · 2024: $595 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,408.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,407.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $469.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $442.98 | 2020-2025 | Nucala, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $383.91 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $153.37 | 2019-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $131.36 | 2019-2025 | Fasenra |
| Merck Sharp & Dohme LLC | $119.93 | 2022-2024 | Dificid, Zerbaxa |
| United Therapeutics Corporation | $75.32 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.98 | 2024-2025 | Lifevest |
| Gilead Sciences, INC. | $70.02 | 2023-2024 | Veklury |
| Abbvie INC. | $45.32 | 2021 | |
| Abbott Laboratories | $39.01 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Actelion Pharmaceuticals US, INC. | $30.41 | 2025 | Uptravi |
| Scpharmaceuticals INC. | $26.69 | 2025 | |
| Boston Scientific Corporation | $26.67 | 2025 | General - Therapies |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.30 | 2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $25.20 | 2024 | Sapien 3 Ultra Resilia |
| Solventum Corporation | $21.76 | 2025 | Prevena, Activ.A.C. |
| Stryker Corporation | $21.46 | 2025 | Clottriever Bold Catheter |
| Medtronic Vascular, INC. | $20.70 | 2019 | |
| Allergan, INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarick Doleh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.